BioCentury
ARTICLE | Strategy

Big play in rheumatoid arthritis

October 2, 1995 7:00 AM UTC

Noteworthy

Glaxo Wellcome plc has made a major commitment to development of a novel treatment that, if successful, would be the first product for rheumatoid arthritis that would both affect the clinical course of the disease and reduce its symptoms...